bf/NASDAQ:ARWR_icon.jpeg

NASDAQ:ARWR

Arrowhead Pharmaceuticals, Inc.

  • Stock

USD

Last Close

22.33

22/04 16:59

Market Cap

3.52B

Beta: 1.01

Volume Today

310.82K

Avg: 1.11M

PE Ratio

−16.68

PFCF: −12.05

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    arrowheadpharma.com
  • ipo date

    Dec 16, 1993

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase...Show More

Earnings

Earnings per Share (Estimate*)

-1-0.50.512017-05-032018-12-112020-08-052022-02-022023-11-29

Revenue (Estimate*)

200M400M600M800M1B2017-05-032018-12-112020-08-052022-02-022023-11-29

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.